![Anders Olof Adolf Ekblom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anders Olof Adolf Ekblom
Vorsitzender bei
XSPRAY PHARMA AB
Vermögen: 90 272 $ am 31.07.2026
Profil
Dr. Anders Olof Adolf Ekblom ist Vorsitzender bei Elypta AB, unabhängiger Direktor bei Alligator Bioscience AB, unabhängiger Non-Executive Director bei Mereo BioPharma Group Plc und außerordentlicher Professor am Karolinska Institutet. Er ist Mitglied des Board of Directors bei LEO Pharma A/S, Alligator Bioscience AB, Mereo BioPharma Group Plc, AnaMar AB, Modul 1 Data AB, Forska Sverige, NxtScience AB und Vetenskapsrdet. Dr. Ekblom war zuvor als Vorsitzender bei TFS Trial Form Support AB, als unabhängiger Direktor bei Infant Bacterial Therapeutics AB, als Vorsitzender beim Karolinska University Hospital, als Chief Executive Officer bei AstraZeneca AB und als Chief Executive Officer & Director bei AstraZeneca Plc tätig. Außerdem war er Vorstandsmitglied bei RSPR Pharma AB, Medivir AB, Viscogel AB, SwedenBIO Service AB, Albireo AB, Albireo Ltd., Palette Life Sciences AB und Sllheten Invest AB. Er erhielt seinen Doktortitel vom Karolinska Institutet.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
FLERIE AB 0.04% | 31.12.2025 | 30’831 ( 0.04% ) | 66 251 $ | 31.07.2026 |
| 26.03.2026 | 189’700 ( 0.02% ) | 13 013 $ | 31.07.2026 | |
XSPRAY PHARMA AB 0.01% | 31.12.2025 | 6’221 ( 0.01% ) | 11 007 $ | 31.07.2026 |
Aktive Positionen von Anders Olof Adolf Ekblom
| Unternehmen | Position | Beginn |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Direktor/Vorstandsmitglied | 01.07.2015 |
| XSPRAY PHARMA AB | Vorsitzender | 19.05.2022 |
| FLERIE INVEST AB | Direktor/Vorstandsmitglied | 01.01.2023 |
Synerkine Pharma BV
 Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Engages in developing fusion proteins for treatment of chronic pain and operates medical laboratories | Direktor/Vorstandsmitglied | 01.01.2024 |
Flerie Invest AB
 Flerie Invest AB Investment ManagersFinance Flerie Invest invests in companies located across the globe. The firm targets companies operating in the fields of biotech and pharmaceutical companies sectors. It provide financing for early and growth stage capital requirements and takes a seat on the board. | Direktor/Vorstandsmitglied | - |
XSpray Pharma Futurum AB | Corporate Officer/Principal | - |
Atrogi AB
 Atrogi AB BiotechnologyHealth Technology Engages in research and development, develops & sells type 2 diabetes | Vorsitzender | 01.01.2022 |
NxtScience AB | Direktor/Vorstandsmitglied | - |
Forska Sverige
 Forska Sverige Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Direktor/Vorstandsmitglied | - |
| ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ehemalige bekannte Positionen von Anders Olof Adolf Ekblom
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░ ░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Anders Olof Adolf Ekblom
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
80
Beziehungen ersten Grades
29
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 29 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Medivir AB
 Medivir AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Modul 1 Data AB
 Modul 1 Data AB Information Technology ServicesTechnology Services Provides IT consulting and management services | Technology Services |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alligator Bioscience AB
 Alligator Bioscience AB BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops antibodies for the treatment of cancers | Health Technology |
LEO Pharma A/S
 LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Health Services |
Flerie AB
 Flerie AB Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of inflammation and cancer diseases | Health Technology |
TFS Trial Form Support AB
 TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services Provides clinical trial and contract research services | Commercial Services |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies that address medical needs in the gastrointestinal and liver disease area | Health Technology |
AnaMar AB
 AnaMar AB BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops novel medicine to prevent, heal and slow organ scarring of fibrotic disease | Health Technology |
Xspray Pharma AB
 Xspray Pharma AB Pharmaceuticals: MajorHealth Technology Develops and produces particulate materials for the pharmaceutical industry | Health Technology |
Viscogel AB | |
RSPR Pharma AB
 RSPR Pharma AB Pharmaceuticals: MajorHealth Technology Develops therapeutics for inflammatory vascular diseases | Health Technology |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services Provides educational services | Commercial Services |
Vetenskapsrådet | |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Develops bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders | Health Technology |
Karolinska University Hospital
 Karolinska University Hospital Hospital/Nursing ManagementHealth Services Provides hospital services | Health Services |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Develops products that improve the quality of life for patients | Health Technology |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest invests in companies located across the globe. The firm targets companies operating in the fields of biotech and pharmaceutical companies sectors. It provide financing for early and growth stage capital requirements and takes a seat on the board. | Finance |
Infant Bacterial Therapeutics AB
 Infant Bacterial Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of gastroschisis | Health Technology |
Mereo BioPharma Group Plc
 Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Engages in research and development, develops & sells type 2 diabetes | Health Technology |
Forska Sverige
Forska Sverige Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
NxtScience AB | |
Elypta AB
 Elypta AB Packaged SoftwareTechnology Services Develops and operates software platform for artificial intelligence algorithms trained by our clinical database | Technology Services |
Sällheten Invest AB | |
Synerkine Pharma BV
Synerkine Pharma BV Miscellaneous Commercial ServicesCommercial Services Engages in developing fusion proteins for treatment of chronic pain and operates medical laboratories | Commercial Services |
XSpray Pharma Futurum AB |
